Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Status: | Completed |
---|---|
Conditions: | Pulmonary |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 40 - Any |
Updated: | 11/23/2013 |
Start Date: | February 2010 |
End Date: | August 2014 |
Contact: | Marianne Morrison, RRT, CCRC |
Email: | morrisonm@njhealth.org |
Phone: | 303-398-1621 |
Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a devastating disease marked by progressive lung
scarring leading to multiple life-altering sequelae. The over-arching goals of the
principal investigator's research program are to more fully characterize these sequelae and
to examine interventions that might improve them. The hypotheses of this particular study
are that pulmonary rehabilitation (PR) is one such intervention, and that PR will improve
the sequelae of dyspnea and impairments in functional capacity, cognition, mood and anxiety,
fatigue, and quality of life (QOL) in patients with IPF.
Subjects will come to our center to be enrolled. Baseline data collection (performance of a
six-minute walk test and completion of questionnaires) and randomization to one of two
groups--either Rehab or Wait--will take place at the same enrollment visit if time permits.
Subjects in either group will complete pulmonary rehabilitation, just at slightly different
times, depending on which group they are randomized to.
Pulmonary rehabilitation is a program run by respiratory and/or physical therapists and
other health professionals that involves exercise, education, and support with the goals to
improve functional capacity, symptom management, and well-being. It will last 6-8 weeks,
during which time, subjects will complete 18 approximately hour-long sessions. Pulmonary
rehabilitation may be completed at any local center that makes travel convenient.
Data collection visits will take place at National Jewish Health at baseline, eight weeks
(without intervening pulmonary rehabilitation in the Wait group), after completion of
pulmonary rehabilitation (time varies, depending on the randomization group), and finally
six months after completion of the pulmonary rehabilitation program.
Inclusion Criteria:
- Age > 40 years
- IPF
- Able to walk unassisted for balance
- Able to speak and understand English well enough to complete complex tasks with
directions given in English
Exclusion Criteria:
- Pulmonary fibrosis not due to IPF
- Coexisting comorbid conditions that would make exercise contraindicated
We found this trial at
1
site
National Jewish Health National Jewish Health is known worldwide for treatment of patients with respiratory,...
Click here to add this to my saved trials
